E2F1 and myeloid sarcoma: The clinical and imaging findings in the MS patient group are listed in Table 2. In the comparison of E2F1 protein levels between patient and control groups by gender, no significant difference was found among men; however, women in the MS group showed statistically higher levels (p=0.232, p=0.028).